Associated Papers
The Pharmacogenetics of Efavirenz Metabolism in Children: The Potential Genetic and Medical Contributions to Child Development in the Context of Long-Term ARV Treatment.
Tan M et al.
New Directions for Child and Adolescent Development, 2020
Longrange PCR-based next-generation sequencing in pharmacokinetics and pharmacodynamics study of propofol among patients under general anaesthesia.
Zakerska-Banaszak O et al.
Scientific Reports, 2017
Genetic variants in CYP2B6 and CYP2A6 explain interindividual variation in efavirenz plasma concentrations of HIV-infected children with diverse ethnic origin.
Soeria-Atmadja S et al.
Plos One, 2017
The impact of genetic polymorphisms on the pharmacokinetics of efavirenz in African children.
Bienczak A et al.
British Journal of Clinical Pharmacology, 2016
Contribution of CYP2B6 alleles in explaining extreme (S)-methadone plasma levels: a CYP2B6 gene resequencing study.
Dobrinas M et al.
Pharmacogenetics and Genomics, 2013
Select a paper to view details